메뉴 건너뛰기




Volumn 41, Issue 4, 2010, Pages 732-738

Effect of combined aspirin and extended-release dipyridamole versus clopidogrel on functional outcome and recurrence in acute, mild ischemic stroke: PRoFESS subgroup analysis

Author keywords

Acute stroke; Aspirin; Clopidogrel; Dipyridamole; Ischemic stroke; Outcome; Randomized controlled trial

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; DIPYRIDAMOLE; TELMISARTAN;

EID: 77950259992     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/STROKEAHA.109.564906     Document Type: Article
Times cited : (49)

References (20)
  • 1
    • 0037065502 scopus 로고    scopus 로고
    • Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myo-cardial infarction, and stroke in high risk patients
    • Antithrombotic Trialists Collaboration. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myo-cardial infarction, and stroke in high risk patients. BMJ. 2002;324:71-86.
    • (2002) BMJ , vol.324 , pp. 71-86
  • 2
    • 0030021512 scopus 로고    scopus 로고
    • Aspirin at any dose above 30 mg offers only modest protection after cerebral ischaemia
    • Algra A, van Gijn J. Aspirin at any dose above 30 mg offers only modest protection after cerebral ischaemia. J Neurol Neurosurg Psychiatry. 1996; 60:197-199.
    • (1996) J Neurol Neurosurg Psychiatry , vol.60 , pp. 197-199
    • Algra, A.1    Van Gijn, J.2
  • 3
    • 0030297319 scopus 로고    scopus 로고
    • European Stroke Prevention Study 2. Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke
    • Diener HC, Cunha L, Forbes C, Sivenius J, Smets P, Lowenthal A. European Stroke Prevention Study 2. Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke. J Neurol Sci. 1996;143:1-13.
    • (1996) J Neurol Sci , vol.143 , pp. 1-13
    • Diener, H.C.1    Cunha, L.2    Forbes, C.3    Sivenius, J.4    Smets, P.5    Lowenthal, A.6
  • 4
    • 0030590746 scopus 로고    scopus 로고
    • A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE)
    • Caprie Steering Committee
    • CAPRIE Steering Committee. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). Lancet. 1996;348:1329-1339
    • (1996) Lancet , vol.348 , pp. 1329-1339
  • 5
    • 33646596912 scopus 로고    scopus 로고
    • Aspirin plus dipyridamole versus aspirin alone after cerebral ischaemia of arterial origin (ESPRIT): Randomised controlled trial
    • The ESPRIT Study Group
    • The ESPRIT Study Group. Aspirin plus dipyridamole versus aspirin alone after cerebral ischaemia of arterial origin (ESPRIT): randomised controlled trial. Lancet. 2006;367:1665-1673.
    • (2006) Lancet , vol.367 , pp. 1665-1673
  • 7
    • 3242770664 scopus 로고    scopus 로고
    • Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): Randomised, double-blind, placebo-controlled trial
    • Diener HC, Bogousslavsky J, Brass LM, Cimminiello C, Csiba L, Kaste M, Leys D, Matias-Guiu J, Rupprecht HJ. Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trial. Lancet. 2004;364:331-337
    • (2004) Lancet , vol.364 , pp. 331-337
    • Diener, H.C.1    Bogousslavsky, J.2    Brass, L.M.3    Cimminiello, C.4    Csiba, L.5    Kaste, M.6    Leys, D.7    Matias-Guiu, J.8    Rupprecht, H.J.9
  • 8
    • 0030911057 scopus 로고    scopus 로고
    • The International Stroke Trial (IST); A randomised trial of aspirin, subcutaneous heparin, both, or neither among 19435 patients with acute ischaemic stroke
    • International Stroke Trial Collaborative Group
    • International Stroke Trial Collaborative Group. The International Stroke Trial (IST); a randomised trial of aspirin, subcutaneous heparin, both, or neither among 19435 patients with acute ischaemic stroke. Lancet. 1997; 349:1569-1581.
    • (1997) Lancet , vol.349 , pp. 1569-1581
  • 9
    • 0030985284 scopus 로고    scopus 로고
    • CAST: Randomised placebo-controlled trial of early aspirin use in 20,000 patients with acute ischaemic stroke
    • CAST (Chinese Acute Stroke Trial) Collaborative Group.
    • CAST (Chinese Acute Stroke Trial) Collaborative Group. CAST: randomised placebo-controlled trial of early aspirin use in 20,000 patients with acute ischaemic stroke. Lancet. 1997;349:1641-1649.
    • (1997) Lancet , vol.349 , pp. 1641-1649
  • 10
    • 35248821708 scopus 로고    scopus 로고
    • Fast assessment of stroke and transient ischaemic attack to prevent early recurrence (FASTER): A randomised controlled pilot trial
    • for the FASTER Investigators
    • Kennedy J, Hill MD, Ryckborst K, Elliaziw M, Demchuk MAM, Buchan AM, for the FASTER Investigators. Fast assessment of stroke and transient ischaemic attack to prevent early recurrence (FASTER): a randomised controlled pilot trial. Lancet Neurol. 2007;6:961-969.
    • (2007) Lancet Neurol , vol.6 , pp. 961-969
    • Kennedy, J.1    Hill, M.D.2    Ryckborst, K.3    Elliaziw, M.4    Demchuk, M.A.M.5    Buchan, A.M.6
  • 11
    • 34147143086 scopus 로고    scopus 로고
    • Rationale, design and baseline data of a randomized, double-blind, controlled trial comparing two antithrombotic regimens (a fixed-dose combination of extended-release dipyridamole plus ASA with clopidogrel) and telmisartan versus placebo in patients with strokes: The prevention regimen for effectively avoiding second strokes trial (PRoFESS)
    • for the Steering Committee and PRoFESS Study Group
    • Diener H-C, Sacco RL, Yusuf S, for the Steering Committee and PRoFESS Study Group. Rationale, design and baseline data of a randomized, double-blind, controlled trial comparing two antithrombotic regimens (a fixed-dose combination of extended-release dipyridamole plus ASA with clopidogrel) and telmisartan versus placebo in patients with strokes: the prevention regimen for effectively avoiding second strokes trial (PRoFESS). Cerebrovasc Dis. 2007;23:368-380.
    • (2007) Cerebrovasc Dis , vol.23 , pp. 368-380
    • Diener, H.-C.1    Sacco, R.L.2    Yusuf, S.3
  • 16
    • 34249829251 scopus 로고    scopus 로고
    • The Optimising Analysis of Stroke Trials (OAST) Collaboration. Can we improve the statistical analysis of stroke trials? statistical re-analysis of functional outcomes in stroke trials
    • The Optimising Analysis of Stroke Trials (OAST) Collaboration. Can we improve the statistical analysis of stroke trials? statistical re-analysis of functional outcomes in stroke trials. Stroke. 2007;38:1911-1915.
    • (2007) Stroke , vol.38 , pp. 1911-1915
  • 17
    • 54049099977 scopus 로고    scopus 로고
    • Use of ordinal outcomes in vascular prevention trials: Comparison with binary outcomes in published stroke trials
    • Bath PMW, Geeganage CM, Gray LJ, Collier T, Pocock S. Use of ordinal outcomes in vascular prevention trials: comparison with binary outcomes in published stroke trials. Stroke. 2008;39:2817-2823.
    • (2008) Stroke , vol.39 , pp. 2817-2823
    • Bath, P.M.W.1    Geeganage, C.M.2    Gray, L.J.3    Collier, T.4    Pocock, S.5
  • 18
    • 0023472546 scopus 로고
    • European stroke prevention study: Principle end points
    • European Stroke Prevention Study Group (ESPS)
    • European Stroke Prevention Study Group (ESPS). European stroke prevention study: principle end points. Lancet. 1987;2:1351-1354.
    • (1987) Lancet , vol.2 , pp. 1351-1354
  • 19
    • 51349157097 scopus 로고    scopus 로고
    • A randomised controlled trial of triplet antiplatelet therapy (aspirin, clopidogrel and dipyridamole) in the secondary prevention of stroke: Safety, tolerability and feasibility
    • Sprigg N, Gray LJ, England T, Willmot MR, Zhao L, Sare GM, Bath PMW. A randomised controlled trial of triplet antiplatelet therapy (aspirin, clopidogrel and dipyridamole) in the secondary prevention of stroke: safety, tolerability and feasibility. PloS One. 2008;3:e2852.
    • (2008) PloS One , vol.3
    • Sprigg, N.1    Gray, L.J.2    England, T.3    Willmot, M.R.4    Zhao, L.5    Sare, G.M.6    Bath, P.M.W.7
  • 20
    • 18244404294 scopus 로고    scopus 로고
    • Dual antiplatelet therapy with clopidogrel and aspirin in symptomatic carotid stenosis evaluated using Doppler embolic signal detection; The clopidogrel and aspirin for reduction of emboli in symptomatic carotid stenosis (CARESS) trial
    • Markus HS, Droste DW, Kaps M, Larrue V, Lees KR, Siebler M, Ringelstein EB. Dual antiplatelet therapy with clopidogrel and aspirin in symptomatic carotid stenosis evaluated using Doppler embolic signal detection; the clopidogrel and aspirin for reduction of emboli in symptomatic carotid stenosis (CARESS) trial. Circulation. 2005;111: 2233-2240.
    • (2005) Circulation , vol.111 , pp. 2233-2240
    • Markus, H.S.1    Droste, D.W.2    Kaps, M.3    Larrue, V.4    Lees, K.R.5    Siebler, M.6    Ringelstein, E.B.7


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.